Jie Jin

发表论文 456 篇 · 总被引 12279 次 · h-index 49

代表论文

• Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial. (2021 · The Lancet Oncology · 被引 108)
• A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia (2021 · Journal of Hematology & Oncology · 被引 70)
• The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma (2021 · Clinical Cancer Research · 被引 67)
• Current views on the genetic landscape and management of variant acute promyelocytic leukemia (2021 · Biomarker Research · 被引 61)
• Hyperthermia Selectively Destabilizes Oncogenic Fusion Proteins. (2021 · Cancer Discovery · 被引 36)
• Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199 (2021 · Journal of Translational Medicine · 被引 35)